Treatment as Prevention ANRS 12249 - datasets for Lancet HIV pain paper
South Africa, 2012 - 2016
Get Microdata
Reference ID
ANRS12249TasP.3ie.main.paper
Producer(s)
Dabis, François, Newell, Marie-Louise, Pillay, Deenan
Collections
Metadata
Created on
Jan 30, 2018
Last modified
Feb 02, 2018
Page views
357797
Downloads
4626
- Data files
-
HIV Drug
Treatments - Households
- CHEs
-
Lab Test
Results -
ARTemis Lab
Results -
ARTemis
Patients -
CHE Adverse
Events - SCBs SCCs
-
CHE Action
Plans - Clusters
- Visits
- HHIs
- CFUs
- CFU Pill Tests
- Local Areas
- Census Rounds
- SCIs
-
Individual
Consents -
SAEs Initial
Notifications -
SAEs Initial
Notifications -
Events details -
SAEs Initial
Notifications -
Medications -
SAEs
Complementary
Notifications -
SAEs
Complementary
Notifications -
Medications - CBCs
- Specimens
- IQs
-
Minority
Variants - BMQ Surveys
- NGS Genomics
- Refusals
- NgsAssembQuality
- Sample Genomics
- Locations
- LinkToCareTracker
- Exits
-
ACCDB
Encounters -
ACCDB Encounter
Therapies - Individuals
- Trial Statuses
-
DBS results
expanded
Organism (Organism)
Data file: NGS Genomics
Overview
Valid:
722
Type:
Discrete
Width:
244
Range:
-
Format:
character
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| HIV-1 | 493 |
68.3%
|
|
| HIV-10 | 3 |
0.4%
|
|
| HIV-11 | 3 |
0.4%
|
|
| HIV-12 | 3 |
0.4%
|
|
| HIV-13 | 3 |
0.4%
|
|
| HIV-14 | 3 |
0.4%
|
|
| HIV-15 | 3 |
0.4%
|
|
| HIV-16 | 3 |
0.4%
|
|
| HIV-17 | 3 |
0.4%
|
|
| HIV-18 | 3 |
0.4%
|
|
| HIV-19 | 3 |
0.4%
|
|
| HIV-2 | 3 |
0.4%
|
|
| HIV-20 | 3 |
0.4%
|
|
| HIV-21 | 3 |
0.4%
|
|
| HIV-22 | 3 |
0.4%
|
|
| HIV-23 | 3 |
0.4%
|
|
| HIV-24 | 3 |
0.4%
|
|
| HIV-25 | 3 |
0.4%
|
|
| HIV-26 | 3 |
0.4%
|
|
| HIV-27 | 3 |
0.4%
|
|
| HIV-28 | 3 |
0.4%
|
|
| HIV-29 | 3 |
0.4%
|
|
| HIV-3 | 3 |
0.4%
|
|
| HIV-30 | 3 |
0.4%
|
|
| HIV-31 | 3 |
0.4%
|
|
| HIV-32 | 3 |
0.4%
|
|
| HIV-33 | 3 |
0.4%
|
|
| HIV-34 | 3 |
0.4%
|
|
| HIV-35 | 3 |
0.4%
|
|
| HIV-36 | 3 |
0.4%
|
|
| HIV-37 | 3 |
0.4%
|
|
| HIV-38 | 3 |
0.4%
|
|
| HIV-39 | 3 |
0.4%
|
|
| HIV-4 | 3 |
0.4%
|
|
| HIV-40 | 3 |
0.4%
|
|
| HIV-41 | 3 |
0.4%
|
|
| HIV-42 | 3 |
0.4%
|
|
| HIV-43 | 3 |
0.4%
|
|
| HIV-44 | 3 |
0.4%
|
|
| HIV-45 | 3 |
0.4%
|
|
| HIV-46 | 3 |
0.4%
|
|
| HIV-47 | 3 |
0.4%
|
|
| HIV-48 | 3 |
0.4%
|
|
| HIV-49 | 3 |
0.4%
|
|
| HIV-5 | 3 |
0.4%
|
|
| HIV-50 | 3 |
0.4%
|
|
| HIV-51 | 3 |
0.4%
|
|
| HIV-52 | 3 |
0.4%
|
|
| HIV-53 | 3 |
0.4%
|
|
| HIV-54 | 3 |
0.4%
|
|
| HIV-55 | 3 |
0.4%
|
|
| HIV-56 | 3 |
0.4%
|
|
| HIV-57 | 3 |
0.4%
|
|
| HIV-58 | 3 |
0.4%
|
|
| HIV-59 | 3 |
0.4%
|
|
| HIV-6 | 3 |
0.4%
|
|
| HIV-60 | 3 |
0.4%
|
|
| HIV-61 | 3 |
0.4%
|
|
| HIV-62 | 3 |
0.4%
|
|
| HIV-63 | 3 |
0.4%
|
|
| HIV-64 | 3 |
0.4%
|
|
| HIV-65 | 3 |
0.4%
|
|
| HIV-66 | 3 |
0.4%
|
|
| HIV-67 | 2 |
0.3%
|
|
| HIV-68 | 2 |
0.3%
|
|
| HIV-69 | 2 |
0.3%
|
|
| HIV-7 | 3 |
0.4%
|
|
| HIV-70 | 2 |
0.3%
|
|
| HIV-71 | 2 |
0.3%
|
|
| HIV-72 | 2 |
0.3%
|
|
| HIV-73 | 2 |
0.3%
|
|
| HIV-74 | 2 |
0.3%
|
|
| HIV-75 | 2 |
0.3%
|
|
| HIV-76 | 2 |
0.3%
|
|
| HIV-77 | 1 |
0.1%
|
|
| HIV-78 | 1 |
0.1%
|
|
| HIV-79 | 1 |
0.1%
|
|
| HIV-8 | 3 |
0.4%
|
|
| HIV-80 | 1 |
0.1%
|
|
| HIV-81 | 1 |
0.1%
|
|
| HIV-82 | 1 |
0.1%
|
|
| HIV-83 | 1 |
0.1%
|
|
| HIV-84 | 1 |
0.1%
|
|
| HIV-85 | 1 |
0.1%
|
|
| HIV-86 | 1 |
0.1%
|
|
| HIV-87 | 1 |
0.1%
|
|
| HIV-88 | 1 |
0.1%
|
|
| HIV-89 | 1 |
0.1%
|
|
| HIV-9 | 3 |
0.4%
|
|
| HIV-90 | 1 |
0.1%
|
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.